Heart Failure Pathophysiology Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Heart Failure Pathophysiology. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Heart Failure Pathophysiology Indian Medical PG Question 1: A 52-year-old woman has long-standing rheumatoid arthritis (RA) and is being treated with corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs). Which of the following cardiac complications may arise in this clinical setting?
- A. Hypertrophic cardiomyopathy
- B. Restrictive cardiomyopathy
- C. Dilated cardiomyopathy
- D. Constrictive pericarditis (Correct Answer)
Heart Failure Pathophysiology Explanation: ***Constrictive pericarditis***
- Chronic **inflammation** associated with rheumatoid arthritis can lead to pericardial involvement, often manifesting as **pericardial effusion** or **fibrosis**. [1]
- Over time, this fibrosis can progress to **pericardial thickening** and calcification, impairing diastolic filling and causing symptoms of constrictive pericarditis. [1]
*Hypertrophic cardiomyopathy*
- This condition is characterized by **left ventricular hypertrophy** without an identifiable cause like hypertension or aortic stenosis.
- It is primarily a **genetic disorder** of the sarcomere and is not typically associated with rheumatoid arthritis or its treatments. [2]
*Restrictive cardiomyopathy*
- Characterized by stiff, non-compliant ventricular walls that restrict diastolic filling, often due to **infiltrative diseases** like amyloidosis or sarcoidosis. [2]
- While RA can cause amyloidosis, it is not the most direct or common cardiac complication, and this diagnosis focuses on myocardial stiffness rather than pericardial disease. [3, 4]
*Dilated cardiomyopathy*
- Involves **enlargement and weakening** of the heart ventricles, leading to impaired systolic function.
- It can be caused by various factors including viral infections, alcohol, or genetic predisposition, but is not a typical direct cardiac complication of rheumatoid arthritis. [2]
Heart Failure Pathophysiology Indian Medical PG Question 2: What is the physiological response of the kidney during shock?
- A. GFR decreases
- B. Perfusion of kidney decreases
- C. Afferent arteriole resistance increases
- D. Renal blood flow decreases (Correct Answer)
Heart Failure Pathophysiology Explanation: ***Renal blood flow decreases***
- During shock, the **primary and most fundamental** physiological change affecting the kidney is a marked **reduction in renal blood flow (RBF)**.
- Shock triggers intense **sympathetic activation** and **renin-angiotensin system (RAS) activation**, causing preferential **vasoconstriction** of renal vessels to redirect blood to vital organs (brain, heart).
- RBF can drop to as low as **20-30% of normal** in severe shock, making this the hallmark renal response.
- This reduction in RBF is the **upstream event** that triggers all other renal changes during shock.
*Perfusion of kidney decreases*
- While technically correct, "decreased perfusion" is **essentially synonymous** with decreased blood flow in this context.
- The term "renal blood flow" is the **standard physiological terminology** used in medical literature to describe this phenomenon, making it the more precise answer.
*Afferent arteriole resistance increases*
- This is a **mechanism** by which RBF decreases, not the overall response itself.
- Increased afferent arteriolar resistance is **secondary** to sympathetic activation and angiotensin II effects during shock.
- It describes the "how" rather than the "what" of the kidney's response.
*GFR decreases*
- GFR reduction is a **consequence** of decreased RBF and increased afferent arteriolar resistance.
- While clinically important (oliguria/acute kidney injury), it's a **downstream effect** rather than the primary physiological response.
- The relationship: ↓RBF → ↓Glomerular hydrostatic pressure → ↓GFR
Heart Failure Pathophysiology Indian Medical PG Question 3: High-output cardiac failure is seen in:
- A. Thyrotoxicosis (Hyperthyroidism) (Correct Answer)
- B. Heart failure with preserved ejection fraction (HFpEF)
- C. Cor pulmonale (Right heart failure due to pulmonary hypertension)
- D. Aortic stenosis (Obstruction to left ventricular outflow)
Heart Failure Pathophysiology Explanation: ***Thyrotoxicosis (Hyperthyroidism)***
- High levels of thyroid hormones increase **basal metabolic rate** and cardiac output, leading to a state where the heart struggles to meet the body's excessive demands despite a normal or even elevated cardiac output.
- This chronic state of increased cardiac workload can eventually lead to cardiac enlargement and **heart failure** despite good systolic function.
*Heart failure with preserved ejection fraction (HFpEF)*
- HFpEF is characterized by **diastolic dysfunction**, where the heart's pumping ability is normal but its relaxation and filling are impaired [1].
- While it represents a type of heart failure, it's typically understood as a **low-output state** or normal-output state relative to demand, not a high-output state caused by increased metabolic needs [2].
*Cor pulmonale (Right heart failure due to pulmonary hypertension)*
- Cor pulmonale is **right ventricular failure** resulting from pulmonary hypertension, where the right side of the heart struggles to pump against increased resistance in the pulmonary circulation.
- This condition is characterized by **elevated pulmonary vascular resistance** and often reduced cardiac output, not an intrinsic high-output state.
*Aortic stenosis (Obstruction to left ventricular outflow)*
- Aortic stenosis causes an **obstruction to blood flow** from the left ventricle, leading to increased pressure load on the left ventricle and eventual concentric hypertrophy.
- This condition typically results in a **reduced or normal cardiac output** because of the outflow obstruction and is not considered a high-output state.
Heart Failure Pathophysiology Indian Medical PG Question 4: Which biomarker is typically elevated in the plasma of patients with chronic heart disease?
- A. Endothelin-1
- B. Troponin T
- C. B-type natriuretic peptide (BNP) (Correct Answer)
- D. Cortisol
Heart Failure Pathophysiology Explanation: ***B-type natriuretic peptide (BNP)***
- **BNP** is a hormone secreted by **ventricular cardiomyocytes** in response to increased wall stretch and pressure overload, making it a strong indicator of **myocardial stress** and **chronic heart failure** [1].
- Elevated levels correlate with the **severity of heart failure**, aiding in diagnosis and prognosis [1].
*Endothelin-1*
- **Endothelin-1** is a potent **vasoconstrictor** involved in vascular tone regulation and endothelial dysfunction.
- While it can be elevated in conditions like **pulmonary hypertension** and **atherosclerosis**, it is not a primary diagnostic biomarker for chronic heart disease in general.
*Troponin T*
- **Troponin T** is a cardiac-specific protein that is released into the bloodstream following **myocardial injury or necrosis**.
- While it is a crucial biomarker for **acute coronary syndromes** (e.g., heart attack), persistently elevated levels are not typical for stable chronic heart disease unless there is ongoing subclinical myocardial damage.
*Cortisol*
- **Cortisol** is a **stress hormone** produced by the adrenal glands, involved in metabolism, immune response, and blood pressure regulation.
- While chronic stress can impact cardiovascular health, cortisol itself is not a specific diagnostic biomarker for chronic heart disease.
Heart Failure Pathophysiology Indian Medical PG Question 5: All drugs decrease mortality in heart failure except:
- A. Enalapril
- B. Metoprolol
- C. Digoxin (Correct Answer)
- D. Telmisartan
Heart Failure Pathophysiology Explanation: ***Digoxin***
- **Digoxin** is known to improve symptoms and reduce hospitalizations in heart failure, but it has **not been shown to decrease mortality** in large clinical trials (DIG trial).
- Its narrow **therapeutic window** and potential for toxicity, especially in patients with renal impairment, limit its use primarily to symptom management.
*Metoprolol*
- **Metoprolol succinate**, a beta-blocker, significantly reduces mortality and morbidity in patients with chronic heart failure with reduced ejection fraction (MERIT-HF trial) by blocking the deleterious effects of the sympathetic nervous system.
- It works by reducing heart rate, myocardial oxygen demand, and cardiac remodeling.
*Enalapril*
- **Enalapril**, an ACE inhibitor, is a cornerstone medication in heart failure treatment due to its proven ability to reduce mortality, hospitalizations, and improve quality of life (CONSENSUS, SOLVD trials).
- It works by blocking the **renin-angiotensin-aldosterone system**, leading to vasodilation, reduced preload and afterload, and prevention of cardiac remodeling.
*Telmisartan*
- **Telmisartan**, an ARB (angiotensin receptor blocker), is used as an alternative in heart failure patients who cannot tolerate ACE inhibitors due to side effects like cough.
- ARBs as a class have shown mortality benefits in heart failure, acting by blocking the **angiotensin II type 1 receptor**, producing similar cardiovascular benefits to ACE inhibitors in terms of vasodilation and reduction in cardiac remodeling.
Heart Failure Pathophysiology Indian Medical PG Question 6: A 50-year-old patient presents with dyspnea, edema, and an elevated JVP. Which condition is most likely?
- A. Right heart failure (Correct Answer)
- B. Left heart failure
- C. Pneumonia
- D. Asthma
Heart Failure Pathophysiology Explanation: ***Right heart failure***
- **Dyspnea**, **edema** (often peripheral), and an **elevated jugular venous pressure (JVP)** are classical signs of right heart failure due to systemic venous congestion [1].
- The inability of the right ventricle to pump blood efficiently leads to blood backing up in the systemic circulation [3].
*Left heart failure*
- While it can cause dyspnea, left heart failure primarily leads to **pulmonary congestion** (e.g., crackles, orthopnea) and is less directly associated with prominent peripheral edema and elevated JVP as initial prominent symptoms [2].
- An elevated JVP and significant peripheral edema in left heart failure typically indicate progression to **biventricular failure** [1].
*Pneumonia*
- Pneumonia typically presents with acute symptoms like **fever, cough with sputum, pleuritic chest pain**, and localized lung findings, rather than chronic dyspnea, edema, and elevated JVP.
- It’s an **infectious lung condition**, not primarily a circulatory disorder causing systemic congestion.
*Asthma*
- Asthma is a **reversible obstructive airway disease** characterized by episodic **wheezing, cough, and shortness of breath** due to bronchospasm [4].
- It does not typically cause edema or an elevated JVP.
Heart Failure Pathophysiology Indian Medical PG Question 7: Which type of white blood cell plays a primary role in cardiac remodeling and chronic inflammation in heart failure?
- A. Eosinophils
- B. Macrophages (Correct Answer)
- C. T cells
- D. B cells
Heart Failure Pathophysiology Explanation: ***Macrophages***
- **Macrophages** are increasingly recognized for their critical role in the pathogenesis and progression of **heart failure**, contributing to **cardiac remodeling**, chronic inflammation, and fibrosis
- They infiltrate failing myocardium and play dual roles: promoting both **inflammation** and **tissue repair**
- Their activation state (M1 vs M2 phenotypes) can significantly influence cardiac function and prognosis in heart failure patients
- They secrete **cytokines**, **growth factors**, and **matrix metalloproteinases** that contribute to ventricular remodeling
*Eosinophils*
- **Eosinophils** are primarily involved in **allergic reactions** and defense against **parasitic infections**
- While they can contribute to inflammation in specific cardiac conditions (e.g., **eosinophilic myocarditis**, **Loeffler endocarditis**), they are not primarily associated with the general pathophysiology of chronic heart failure
*T cells*
- **T cells** are central to **adaptive immunity**, including cell-mediated responses and modulation of immune reactions
- Though T cells play a role in inflammatory processes in certain forms of heart disease, particularly **viral myocarditis**, they are not the predominant immune cell driving chronic cardiac remodeling in heart failure
*B cells*
- **B cells** are responsible for producing **antibodies** and are key players in humoral immunity
- While B cells can contribute to autoimmune forms of heart disease and certain inflammatory processes, they are not typically the primary immune cell associated with the progression of chronic heart failure
Heart Failure Pathophysiology Indian Medical PG Question 8: Which of the following is a stain for heart failure cells?
- A. PAS
- B. Prussian blue (Correct Answer)
- C. Sudan black
- D. Oil red O
Heart Failure Pathophysiology Explanation: ***Prussian blue***
- Heart failure cells are **alveolar macrophages** that have phagocytosed **hemosiderin** (iron-laden pigment) from extravasated red blood cells due to **pulmonary congestion** in heart failure.
- The **Prussian blue stain** specifically detects the ferric iron (Fe3+) within hemosiderin, making it the appropriate stain for identifying heart failure cells.
*PAS*
- **Periodic Acid-Schiff (PAS)** stain detects **carbohydrates** such as glycogen, mucins, and glycoproteins, and is used for conditions like **glycogen storage diseases** or certain fungal infections.
- It does not specifically identify iron or hemosiderin, hence it is not used for heart failure cells.
*Sudan black*
- **Sudan black** is a **lipid stain** used to identify intracellular **lipids** and distinguish between different types of leukemia based on the presence of myeloperoxidase.
- It is not designed to detect iron or hemosiderin and thus is not used for heart failure cells.
*Oil red O*
- **Oil Red O** is another common stain for demonstrating neutral **lipids** and triglycerides in frozen tissue sections.
- Like Sudan black, it is a lipid stain and therefore would not be helpful in identifying the iron-laden hemosiderin characteristic of heart failure cells.
Heart Failure Pathophysiology Indian Medical PG Question 9: Heart failure cells are
- A. Lipofuscin granules in cardiac cells
- B. Pigmented alveolar macrophages (Correct Answer)
- C. Pigmented pancreatic acinar cells
- D. Pigment cells seen in liver
Heart Failure Pathophysiology Explanation: ***Pigmented alveolar macrophages***
- These macrophages engulf **hemosiderin** (iron-rich pigment from degraded red blood cells) that leaks into the alveoli due to increased capillary pressure in left-sided **heart failure**.
- The presence of **hemosiderin-laden macrophages** in the sputum or lung tissue is diagnostic for chronic pulmonary congestion caused by heart failure.
*Lipofuscin granules in cardiac cells*
- **Lipofuscin** is a "wear-and-tear" pigment that accumulates in aging cells, including cardiac cells.
- While present in older hearts, its presence does not specifically indicate **heart failure** or represent "heart failure cells" in the described context.
*Pigmented pancreatic acinar cells*
- Pancreatic acinar cells primarily produce digestive enzymes and are not typically associated with **pigment accumulation** in the context of heart failure.
- Pigmentation in pancreatic cells would suggest other pathologies, such as **hemochromatosis** affecting the pancreas.
*Pigment cells seen in liver*
- The liver can accumulate various pigments, such as **hemosiderin** in hemochromatosis or **bilirubin** in cholestasis.
- While liver congestion can occur in right-sided heart failure, the specific "heart failure cells" refer to the **pulmonary macrophages**.
Heart Failure Pathophysiology Indian Medical PG Question 10: Concentric hypertrophy of left ventricle is seen in -
- A. Congenital aortic stenosis due to bicuspid aortic valve (Correct Answer)
- B. Mitral Stenosis
- C. Aortic Regurgitation
- D. Hypertrophic Obstructive Cardiomyopathy
Heart Failure Pathophysiology Explanation: ***Congenital aortic stenosis due to bicuspid aortic valve***
- **Aortic stenosis** creates a **pressure overload** on the left ventricle, leading to a compensatory increase in myocardial wall thickness without significant chamber dilation, which is the classic example of **concentric hypertrophy** [1].
- A **bicuspid aortic valve** is a common congenital anomaly that causes aortic stenosis and thus concentric left ventricular hypertrophy [2].
- This represents **acquired concentric hypertrophy** due to hemodynamic stress.
*Mitral Stenosis*
- **Mitral stenosis** primarily causes a pressure overload on the **left atrium**, leading to left atrial enlargement [3].
- While it can indirectly affect the left ventricle, it typically does not cause **concentric left ventricular hypertrophy** itself.
*Aortic Regurgitation*
- **Aortic regurgitation** leads to a **volume overload** on the left ventricle as blood flows back into the ventricle during diastole.
- This typically results in **eccentric hypertrophy**, where both the ventricular wall thickness and chamber size increase significantly (dilated ventricle with increased mass) [1].
*Hypertrophic Obstructive Cardiomyopathy*
- **Hypertrophic obstructive cardiomyopathy (HOCM)** is a **primary genetic myocardial disease** characterized by **asymmetric septal hypertrophy** rather than uniform concentric hypertrophy.
- While HOCM involves significant myocardial hypertrophy, it represents a distinct pathophysiologic entity with **asymmetric distribution** (predominantly septal), not the classic concentric pattern seen with pressure overload states.
- The hypertrophy in HOCM is **intrinsic (genetic)** rather than **adaptive (hemodynamic)** like in aortic stenosis.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, p. 536.
[2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 562-563.
[3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 533-534.
More Heart Failure Pathophysiology Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
